[go: up one dir, main page]

FI20040572A0 - Matriisi-metalloproteinaasin aktiviteetin inhibiittorit - Google Patents

Matriisi-metalloproteinaasin aktiviteetin inhibiittorit

Info

Publication number
FI20040572A0
FI20040572A0 FI20040572A FI20040572A FI20040572A0 FI 20040572 A0 FI20040572 A0 FI 20040572A0 FI 20040572 A FI20040572 A FI 20040572A FI 20040572 A FI20040572 A FI 20040572A FI 20040572 A0 FI20040572 A0 FI 20040572A0
Authority
FI
Finland
Prior art keywords
inhibitors
matrix metalloproteinase
metalloproteinase activity
activity
matrix
Prior art date
Application number
FI20040572A
Other languages
English (en)
Swedish (sv)
Inventor
Mikael Bjoerklund
Erkki Koivunen
Original Assignee
Ctt Cancer Targeting Tech Oy
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ctt Cancer Targeting Tech Oy filed Critical Ctt Cancer Targeting Tech Oy
Priority to FI20040572A priority Critical patent/FI20040572A0/fi
Publication of FI20040572A0 publication Critical patent/FI20040572A0/fi
Priority to PCT/FI2005/050130 priority patent/WO2005103071A1/en
Priority to US11/578,793 priority patent/US20070207967A1/en
Priority to EP05735251A priority patent/EP1737882A1/en
Priority to CA002564453A priority patent/CA2564453A1/en
Priority to JP2007508922A priority patent/JP2007537162A/ja

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/81—Protease inhibitors
    • C07K14/8107—Endopeptidase (E.C. 3.4.21-99) inhibitors
    • C07K14/8146—Metalloprotease (E.C. 3.4.24) inhibitors, e.g. tissue inhibitor of metallo proteinase, TIMP
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Molecular Biology (AREA)
  • Rheumatology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Dermatology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pulmonology (AREA)
  • Virology (AREA)
  • Immunology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Oncology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • AIDS & HIV (AREA)
  • Communicable Diseases (AREA)
  • Cardiology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Pain & Pain Management (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Enzymes And Modification Thereof (AREA)
FI20040572A 2004-04-23 2004-04-23 Matriisi-metalloproteinaasin aktiviteetin inhibiittorit FI20040572A0 (fi)

Priority Applications (6)

Application Number Priority Date Filing Date Title
FI20040572A FI20040572A0 (fi) 2004-04-23 2004-04-23 Matriisi-metalloproteinaasin aktiviteetin inhibiittorit
PCT/FI2005/050130 WO2005103071A1 (en) 2004-04-23 2005-04-21 Peptide inhibitors of metalloproteinase activity
US11/578,793 US20070207967A1 (en) 2004-04-23 2005-04-21 Peptide Inhibitors of Matrix Metalloproteinase Activity
EP05735251A EP1737882A1 (en) 2004-04-23 2005-04-21 Peptide inhibitors of metalloproteinase activity
CA002564453A CA2564453A1 (en) 2004-04-23 2005-04-21 Peptide inhibitors of metalloproteinase activity
JP2007508922A JP2007537162A (ja) 2004-04-23 2005-04-21 マトリックスメタロプロティナーゼの活性に対する阻害能を有する物質

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FI20040572A FI20040572A0 (fi) 2004-04-23 2004-04-23 Matriisi-metalloproteinaasin aktiviteetin inhibiittorit

Publications (1)

Publication Number Publication Date
FI20040572A0 true FI20040572A0 (fi) 2004-04-23

Family

ID=32104209

Family Applications (1)

Application Number Title Priority Date Filing Date
FI20040572A FI20040572A0 (fi) 2004-04-23 2004-04-23 Matriisi-metalloproteinaasin aktiviteetin inhibiittorit

Country Status (6)

Country Link
US (1) US20070207967A1 (fi)
EP (1) EP1737882A1 (fi)
JP (1) JP2007537162A (fi)
CA (1) CA2564453A1 (fi)
FI (1) FI20040572A0 (fi)
WO (1) WO2005103071A1 (fi)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2635605C (en) 2006-01-10 2014-07-08 Colgate-Palmolive Company Methods of modulating cell surface receptors to prevent or reduce inflammation
MX2010001657A (es) * 2007-08-15 2010-03-15 Yeda Res & Dev Reguladores de mmp-9 y usos de los mismos.
WO2009079585A2 (en) 2007-12-17 2009-06-25 Dyax Corp. Compositions and methods for treating osteolytic disorders comprising mmp-14 binding proteins
WO2009111450A2 (en) * 2008-03-03 2009-09-11 Dyax Corp. Metalloproteinase 9 binding proteins
WO2009126805A2 (en) * 2008-04-11 2009-10-15 The Board Of Regents Of The Univeristy Of Texas System Therapeutic tarageting of mmps in neutral liposomes
TWI481870B (zh) * 2009-04-01 2015-04-21 Colgate Palmolive Co 用於軟組織疾病診斷及作為用於口腔保健干預的標靶之蛋白質生物標記
JP5550717B2 (ja) 2009-04-01 2014-07-16 コルゲート・パーモリブ・カンパニー メントール誘導体ならびに口腔活性剤および全身活性剤としてのそれらの使用
AR076177A1 (es) * 2009-04-01 2011-05-26 Colgate Palmolive Co MÉTODO PARA IDENTIFICAR UN COMPUESTO uTIL PARA TRATAR UNA ENFERMEDAD O CONDICIoN DE LA CAVIDAD ORAL
BRPI0924882A2 (pt) 2009-04-01 2015-07-07 Colgate Palmolive Co Composição para cuidado oral, e, uso de pelo menos um composto de carbonato e pelo menos um excipiente
KR101363455B1 (ko) * 2011-09-09 2014-02-21 (주)케어젠 매트릭스 메탈로프로테아제 활성 억제 펩타이드 및 이의 용도
WO2013059439A2 (en) 2011-10-21 2013-04-25 Dyax Corp. Combination therapy comprising an mmp-14 binding protein
WO2016196350A1 (en) * 2015-05-29 2016-12-08 New York University Auf1 encoding compositions for muscle cell uptake, satellite cell populations, and satellite cell mediated muscle generation

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI980604A0 (fi) * 1998-03-18 1998-03-18 Univ Helsinki Licensing Nya matrismetalloproteinasinhibitorer och -regulatorer
FI113840B (fi) * 2001-03-26 2004-06-30 Ctt Cancer Targeting Tech Oy Matriisi-metalloproteinaasi-inhibiittorien käyttö liposomien kohdentamisessa

Also Published As

Publication number Publication date
WO2005103071A1 (en) 2005-11-03
JP2007537162A (ja) 2007-12-20
US20070207967A1 (en) 2007-09-06
EP1737882A1 (en) 2007-01-03
CA2564453A1 (en) 2005-11-03

Similar Documents

Publication Publication Date Title
CY2022001I1 (el) Παραγωγα του uk-2a
CY2013042I1 (el) Αναστολεις πυριδυλιου της σηματοδοτησης hedgehog
DK1940839T3 (da) Pyridopyrimidione Inhibitors of P13Ka
CY2014012I2 (el) Χορηγηση αναστολεων διπεπτιδυλοπεπτιδασης
DK1898903T3 (da) Inhibitorer af Akt-aktivitet
DK1848718T3 (da) E1 aktiveringsenzymhæmmere
ATE423121T1 (de) Diphenylimidazopyrimidin- und -imidazolamine als b-sekretase-inhibitoren
DK1720866T3 (da) Fremgangsmåde
DE602005019971D1 (de) Inhibitoren von cysteinprotease
EP1704145A4 (en) SELECTIVE KINASEINHIBITORS
ATE446090T1 (de) Thiadiazolidinone als gsk3-inhibitoren
ITMI20050191A1 (it) Struttura di fet ad alette
PT1586571E (pt) Inibidores da dipeptidil-peptidase
DK1781752T3 (da) Grovkornet mikrokapselmiddel
DK1802872T3 (da) Rörledning
DE602004018837D1 (de) Ptidase-iv-inhibitoren
ITMI20041869A1 (it) Nuovi inibitori delle istone deacetilasi
DK2589599T3 (da) Hidtil ukendte hydroxy-6-heteroarylphenanthridiner og deres anvendelse som PDE4-inhibitorer
FI20040572A0 (fi) Matriisi-metalloproteinaasin aktiviteetin inhibiittorit
EP1868601A4 (en) MITOTIC KINESINE HEMMER
EP1613311A4 (en) HIF-1 INHIBITORS
ATE545642T1 (de) Mmp-inhibitoren
DK1781618T3 (da) Sigma-receptorinhibitorer
EP1772148A4 (en) Lipase inhibitors
EP1767204A4 (en) LIPASE INHIBITORS

Legal Events

Date Code Title Description
FD Application lapsed